VEGF121b and VEGF165b: Weak Angiogenic Isoforms of VEGF-A
Author Information
Author(s): Catena Raúl, Larzabal Leyre, Larrayoz Marta, Molina Eva, Hermida Jose, Agorreta Jackeline, Montes Ramon, Pio Ruben, Montuenga Luis M, Calvo Alfonso
Primary Institution: University of Navarra, Pamplona, Spain
Hypothesis
VEGFxxxb isoforms may inhibit angiogenesis.
Conclusion
VEGF121/165b are weakly angiogenic isoforms of VEGF-A that may promote tumor growth and angiogenesis in vivo.
Supporting Evidence
- VEGF121/165b proteins activated VEGFR2 and increased endothelial cell proliferation.
- Immunohistochemical analysis showed increased expression of VEGFxxxb in breast cancer compared to normal tissues.
- VEGF121b and VEGF165b overexpression in xenograft models led to increased tumor volume.
Takeaway
This study found that two specific forms of a protein called VEGF can help tumors grow by making new blood vessels, but they are not very strong at doing this.
Methodology
Recombinant proteins were produced in yeast, and their effects on endothelial cells and tumor growth were assessed in vitro and in vivo.
Limitations
The study primarily focused on specific cancer types and may not generalize to all cancers.
Participant Demographics
Breast cancer patients and normal breast tissue samples were analyzed.
Statistical Information
P-Value
p < 0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website